Growth Metrics

Aurinia Pharmaceuticals (AUPH) Other Accumulated Expenses: 2018-2024

Historic Other Accumulated Expenses for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $1.5 million.

  • Aurinia Pharmaceuticals' Other Accumulated Expenses rose 57.36% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 57.36%. This contributed to the annual value of $1.5 million for FY2024, which is 35.89% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Other Accumulated Expenses stood at $1.5 million for FY2024, which was down 35.89% from $2.4 million recorded in FY2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Other Accumulated Expenses peaked at $6.4 million during FY2020, and registered a low of $1.5 million during FY2024.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Other Accumulated Expenses value was $2.0 million (recorded in 2022), while the average stood at $2.0 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Other Accumulated Expenses surged by 5,333.90% in 2020 and then tumbled by 54.31% in 2022.
  • Yearly analysis of 5 years shows Aurinia Pharmaceuticals' Other Accumulated Expenses stood at $6.4 million in 2020, then crashed by 30.60% to $4.5 million in 2021, then plummeted by 54.31% to $2.0 million in 2022, then rose by 17.46% to $2.4 million in 2023, then crashed by 35.89% to $1.5 million in 2024.